Mohak V Mhatre1, Julie A Potter1, Charles J Lockwood2, Graciela Krikun1, Vikki M Abrahams1. 1. Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. 2. Department of Obstetrics & Gynecology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Abstract
PROBLEM: Risk factors for preterm birth include placental abruption, giving rise to excessive decidual thrombin, and intrauterine bacterial infection. Human endometrial endothelial cells (HEECs) express Toll-like receptors (TLRs), and infection-derived agonists trigger HEECs to generate specific inflammatory responses. As thrombin, in addition to inducing coagulation, can contribute to inflammation, its effect on HEEC inflammatory responses to the TLR4 agonist, bacterial lipopolysaccharide (LPS), was investigated. METHOD OF STUDY: HEECs were pre-treated with or without thrombin or specific protease-activated receptor (PAR) agonists, followed by treatment with or without LPS. Supernatants were measured for cytokines and chemokines by ELISA and multiplex analysis. RESULTS: Thrombin significantly and synergistically augmented LPS-induced HEEC secretion of interleukin (IL)-6, IL-8, granulocyte colony-stimulating factor (G-CSF), and growth-regulated oncogene-alpha (GRO-α), and significantly augmented monocyte chemotactic protein (MCP)-1, tumor necrosis factor-alpha (TNF-α), and vascular endothelial growth factor (VEGF) secretion additively. Similar to thrombin, a PAR1 agonist synergistically augmented the LPS-induced HEEC secretion of inflammatory IL-6, IL-8, G-CSF, and GRO-α. CONCLUSION: Thrombin, via PAR1 activation, synergistically augments LPS-induced HEEC production of chemokines involved in immune cell recruitment and survival, suggesting a mechanism by which intrauterine abruption and bacterial infection may together be associated with an aggravated uterine inflammatory response.
PROBLEM: Risk factors for preterm birth include placental abruption, giving rise to excessive decidual thrombin, and intrauterine bacterial infection. Human endometrial endothelial cells (HEECs) express Toll-like receptors (TLRs), and infection-derived agonists trigger HEECs to generate specific inflammatory responses. As thrombin, in addition to inducing coagulation, can contribute to inflammation, its effect on HEEC inflammatory responses to the TLR4 agonist, bacterial lipopolysaccharide (LPS), was investigated. METHOD OF STUDY: HEECs were pre-treated with or without thrombin or specific protease-activated receptor (PAR) agonists, followed by treatment with or without LPS. Supernatants were measured for cytokines and chemokines by ELISA and multiplex analysis. RESULTS:Thrombin significantly and synergistically augmented LPS-induced HEEC secretion of interleukin (IL)-6, IL-8, granulocyte colony-stimulating factor (G-CSF), and growth-regulated oncogene-alpha (GRO-α), and significantly augmented monocyte chemotactic protein (MCP)-1, tumor necrosis factor-alpha (TNF-α), and vascular endothelial growth factor (VEGF) secretion additively. Similar to thrombin, a PAR1 agonist synergistically augmented the LPS-induced HEEC secretion of inflammatory IL-6, IL-8, G-CSF, and GRO-α. CONCLUSION:Thrombin, via PAR1 activation, synergistically augments LPS-induced HEEC production of chemokines involved in immune cell recruitment and survival, suggesting a mechanism by which intrauterine abruption and bacterial infection may together be associated with an aggravated uterine inflammatory response.
Authors: G Kaplanski; M Fabrigoule; V Boulay; C A Dinarello; P Bongrand; S Kaplanski; C Farnarier Journal: J Immunol Date: 1997-06-01 Impact factor: 5.422
Authors: Matthew W Kemp; Masatoshi Saito; John P Newnham; Ilias Nitsos; Kunihiro Okamura; Suhas G Kallapur Journal: Reprod Sci Date: 2010-07 Impact factor: 3.060
Authors: Carl A Nath; Cande V Ananth; John C Smulian; Susan Shen-Schwarz; Lillian Kaminsky Journal: Am J Obstet Gynecol Date: 2007-09 Impact factor: 8.661
Authors: Vikki M Abrahams; Julie A Potter; Geeta Bhat; Morgan R Peltier; George Saade; Ramkumar Menon Journal: Am J Reprod Immunol Date: 2012-09-11 Impact factor: 3.886
Authors: Cinzia Fabrizi; Elena Pompili; Barbara Panetta; Stefania Lucia Nori; Lorenzo Fumagalli Journal: Int J Mol Med Date: 2009-09 Impact factor: 4.101
Authors: Alexander A Boucher; Leah Rosenfeldt; Duaa Mureb; Jessica Shafer; Bal Krishan Sharma; Adam Lane; Rebecca R Crowther; Melanie C McKell; Jordan Whitt; Theresa Alenghat; Joseph Qualls; Silvio Antoniak; Nigel Mackman; Matthew J Flick; Kris A Steinbrecher; Joseph S Palumbo Journal: J Thromb Haemost Date: 2019-10-11 Impact factor: 5.824
Authors: Mirjam Bachler; Lars M Asmis; Jürgen Koscielny; Thomas Lang; Hartmuth Nowak; Patrick Paulus; Jens-Christian Schewe; Christian von Heymann; Dietmar Fries Journal: Blood Coagul Fibrinolysis Date: 2022-06-08 Impact factor: 1.061
Authors: Naveen Gupta; Ranjeet Sinha; Anna Krasnodembskaya; Xiao Xu; Victor Nizet; Michael A Matthay; John H Griffin Journal: Stem Cells Date: 2018-02-14 Impact factor: 6.277